BioSig Technologies, Inc. STEX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s stock issuance proceeds?
- BioSig Technologies, Inc. (STEX) reported stock issuance proceeds of $37.18K in Q1 2026.
- How has BioSig Technologies, Inc.'s stock issuance proceeds changed year-over-year?
- BioSig Technologies, Inc.'s stock issuance proceeds decreased by 95.5% year-over-year, from $818K to $37.18K.
- What is the long-term trend for BioSig Technologies, Inc.'s stock issuance proceeds?
- Over 3 years (2021 to 2024), BioSig Technologies, Inc.'s stock issuance proceeds has grown at a -22.4% compound annual growth rate (CAGR), from $9.01M to $4.21M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.